Boston, Medtronic Differ On Views For MRI Coverage In Pacemaker Patients
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific says it agrees with CMS' decision to refrain from covering magnetic resonance imaging in cardiac pacemaker and implantable defibrillator patients for now
You may also be interested in...
MRI Coverage Proposals: A 'Go' For Blood Flow, 'No' For Pacemaker Patients
Use of magnetic resonance imaging to assess heart valve disease in Medicare patients may be an easier proposition for physicians if a June 30 CMS coverage 1proposal is adopted
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.